Sunshine Biopharma Inc.
$0.90
Market Cap
$3.26M
Shares Outstanding
3.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 9, 2007
Round Lot
100
Locale
US
Day Open
$0.82
Day High
$0.90
Day Low
$0.82
Volume
157.5K
VWAP
$0.86
Prev Close
$0.84
Transactions
--
Acc. Volume
--
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Sunshine Biopharma Inc. (SBFM) closed the 2026-09-18 session at $0.90, up 6.98% versus the previous close (+0.06). The stock opened at $0.82 and traded between $0.82 and $0.90 during that session. Session trading volume was 158K shares. The volume-weighted average price (VWAP) is $0.86.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Sunshine Biopharma Inc. has a market capitalization of $3.3 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SBFM is listed on the XNAS exchange. The company employs approximately 50 people. Sunshine Biopharma Inc. is headquartered in FORT LAUDERDALE, FL. The recorded listing date is 2007-08-09.
On this page you can find market SBFM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.